In a study conducted by Verschuere et al., the diagnostic potential of serum GAL-1 levels in glial tumors was evaluated and it was reported that in newly diagnosed GBM patients, age- and sex-adjusted serum GAL-1 levels were significantly higher compared to healthy controls [29]. This evidence concerns the gene LGALS1 and glioma.